CHEMTECH World Expo - Chemtech Foundation

Transcription

cmyk
WORLD MEET OF THE PROCESS INDUSTRY IN INDIA
“CATALYSING SUSTAINABLE GROWTH & LEADERSHIP THROUGH INNOVATION”
23rd International Exhibition & Conferences 2007
February 6-10, 2007 Mumbai, India.
IMPRESSIONS
A PICTORIAL JOURNEY
Supported by :
cmyk
CMYK
Beginning of a New Century, the 21st Century,
Beginning of a New Era at CHEMTECH.
Mr. Dhirubhai Ambani receiving the ‘Man of the Century Award’ from
H E Dr. P. C. Alexander, The Governor of Maharashtra.
It was 8th of November 2000, when CHEMTECH Foundation - an industry association for technology transfer and
ungradation - celebrated its silver jubilee. This was also the time when the last few days of the 20th Century were before us
and a new Century was about to begin. This was also a time when India had liberalised its economy for almost a decade.
At the time of the Silver Jubilee of CHEMTECH Foundation and at the time when the legendary Dhirubhai Ambani was
bestowed 'Man of the Century' award by CHEMTECH, it was apt that we look at what should be our path in the new
century, our path in the new era.
02
CMYK
CMYK
We believed that we need to redefine our charter, and it
was then decided that it will be 'CHEMTECH Foundation
'Inspiring Intelligence…….Igniting Innovation'
Of
course, this was not just a slogan - though, a good slogan
it was, but a promise and a commitment to work towards
innovation. At that time we had also announced that you
Mr. Mukesh Ambani
will also see in the next five years, a number of initiatives
by CHEMTECH Foundation that one can almost say
'CHEMTECH Foundation Innovation is at work'.
Mr. Mukesh Ambani, Chairman, Reliance Group and
Chairman, Central Advisory Board, CHEMTECH + Pharma
World Expo 2003 said at the Inaugural function. “ I would
like to touch two initiatives in the field of innovation. I have
Those five years have just been completed and the
CHEMTECH 2007 encompasses some of the new, and
always maintained that innovation in technology will drive
business and economy in the 21st century. The capability in
it will define the competitive advantage and differentiate
we believe some very important, initiatives in this period.
men from boys. CHEMTECH has institutionalised the spirit
What you will see is not only the report of the event of
of innovation of those among you in the from of
CHEMTECH 2007 but also, how the transformation and
CHEMTECH Innovation Forum for young leaders, and this
changes at CHEMTECH are taking place in the ensuing
is laudable. I compliment CHEMTECH for this initiative so
five years.
that the future generation will benefit, and I wish them every
success.”
03
CMYK
CMYK
CHEMTECH INITIATIVES ON INNOVATION
H + PHARMA WORLD EXPO 2
CHEMTEC
007
- FOLLOW UP
Industry experts at MGM College
Study Circle Initiatives :
CHEMTECH had started “Study Circle” programmes during 1980's when 10 students from
leading institutions were invited to visit the exhibition along with their professors. Later on CHEMTECH expanded this facility to include in
International Conferences without charging any fees. This “Study Circle” programme is now being further expanded by inviting 500 students
from all over India.
In addition to this, 3 more initiatives are being taken:
A) Interaction of Industry with Professors/Teachers. B) Interaction with students from Industry experts to inform them about the importance of
disciplines like Chemical Engineering,
Pharmaceutical, Biotechnology, IT as enabler for improving productivity and competitiveness. C)
Involving students of 10th to 12th standards during the two months vacation period in Industry, which provide internship.
04
CMYK
CMYK
Pharma Industry
Initiatives :
The Indian Forum for Good Clinical Practice
(InFo-GCP) : Apart from facilitating ethical and
GCP related discussions, InFo-GCP offers a
platform to update guidelines and working
practices for the purpose of improving clinical
research standards in India. It was launched in
February 2005 and aims to spread awareness
of ethical principles in research and promote
efforts towards its integration in GCP while
conducting such research. This Forum will
InFoGCP Programme in Progress
stimulate a closer relationship and improve
understanding between key stakeholders of the
Clinical Research field. One of the intentions of
this group is to promote Quality Management systems in clinical trials. Another important area of focus would be to foster the development of
Clinical Research professionals by organizing various training programs in specialty areas of Clinical Research. Info-GCP is already active.
Indian Drug Discovery Network International (Indi-NET) : This initiative seeks to highlight India's strengths in drug discovery and
development and will help create a network of Indian talents in drug discovery not only in India but around the world so that this infrastructure
will benefit the entire industry. Dr Somesh Sharma, Chief Scientific Officer, Nicholas Piramal India Limited launched Indi-NET at the recently
concluded CHEMTECH + PHARMA International Conferences 2007 in February 2007.
Indo-Global Partnership in Manufacturing Services. (Indo-MAPS): This initiative will project India's strengths in contract
manufacturing/outsourcing to the world in a better fashion, and will be a neutral forum for all the stakeholders. This initiative was formally
launched at the recently concluded CHEMTECH + PHARMA International Conferences 2007 in February 2007 by Dr Raghunath Mashelkar,
former Director General, Council of Scientific and Industrial Research (CSIR).
05
CMYK
CMYK
LAUNCH OF 2 NEW CHEMTECH INITIATIVES
As a long-term partner to the Indian pharma industry, CHEMTECH Foundation launched two new initiatives to promote the growth of the industry.
The first initiative, Indo-Global Partnership in Manufacturing Services (Indo-MAPS), was launched by Dr R A Mashelkar, former Director General, Council of
Scientific and Industrial Research (CSIR) on February 7th. Indo-MAPS will facilitate India to develop contract manufacturing/outsourcing partnerships with key
global players.
CHEMTEC
007
India is witnessing not just an "expansion" but an
"explosion" of markets. How are we going to
manage this growth expectation? And is this
innovation-led growth? The first challenge facing
India is a tremendous talent crunch, followed by the
challenge to win not on cost but on value arbitrage,
because cost arbitrage is a mirage. In spite of these
challenges, there is no question that India's time has
come. I am happy to launch the CHEMTECH
Initiative Indo-MAPS, and wish the programme a
great success.
Launching of INDO-MAPS Indo-Global Partnership in Manufacturing Services (L to R) Mr. Jasu Shah,
Chairman, CHEMTECH Foundation, Dr. R.A. Mashelkar, Former Director General, CSIR.
DR RAGHUNATH A MASHELKAR,
Former Director General, Council of Scientific and Industrial Research (CSIR)
The second initiative, Indian Drug Discovery Network International (Indi-NET), seeks to highlight India's strengths in drug discovery and development and will
help create a network of Indian talents in drug discovery - not only in India, but around the world so that this Network will benefit the entire industry. This was
launched by Dr Somesh Sharma, Chief Scientific Officer, Nicholas Piramal India Limited at the Valedictory and Awards Function on February 8th evening.
6
Launching of Indian Drug Discovery Network International (Indi-NET) (L to R) Mr. Jasu
Shah, Chairman, CHEMTECH Foundation, Dr. Somesh Sharma, Chief Scientific Officer,
Nicholas Piramal India Ltd., Dr. Laxman Prasad, Head, Division of Technology Transfer in
the Dept. of Science & Technology, Govt. of India, Mr. K.G. Ramanathan, Advisor, Reliance
Industries Ltd.
India can fill the pipeline gap being faced by the global
pharma industry because of the cost advantage. An
initiative such as Indian Drug Discovery Network
International (Indi-NET) can help create an environment
that encourages innovation, creative thinking and most
importantly, risk-taking. CHEMTECH can trigger the
development of a truly world class young generation of
scientists. Indi-NET can also support academia to take
their research and technology to the next stage. And lastly,
it is important to lobby for a uniform regulatory environment. Through all these
activities, Indi-NET can strengthen the linkages between industry, academia
and the government. I wish Indi-NET all success in its future endeavors.
DR SOMESH SHARMA, CSO, Nicholas Piramal India Limited
CMYK
CMYK
THE STUDY CIRCLE INITIATIVE
The 'Study Circle' initiative started in the 1980s by CHEMTECH to invite students along with their Professors/Teachers from institutes and colleges across the
country. This activity was expanded for the 2007 event. Over 300 students along with their faculty heads attended various conferences and visited the
exhibition. They evinced overwhelming interest and interacted with speakers and exhibitors to satisfy their curious minds.
HE PROCESS INDUSTR Y IN IND
MEET OF T
IA
WORLD
The programme was supported by the industry like : Uhde India Ltd., Sukhras Machines Pvt. Ltd., Somaiya Group, Blue Cross Laboratories, Aker Kvaerner Power
Gas Ltd., and United Phosphorous Ltd.
07
CMYK
CMYK
INAUGURATION
CHEMTECH+PHARMA 2007 International Exhibitions and Conferences began with a glittering Function on February 6, 2007.
The inauguration of the event was held at NSE complex in Mumbai's western suburb of Goregaon.
CHEMTEC
007
The event was the 23rd one in the CHEMTECH series and had a theme "Catalysing Sustainable growth and Leadership through
Innovation ". Mr. Nikhil Meswani, Executive Director & Member of the Board, Reliance Industries Ltd., & Chairman, Central Advisory
Board, CHEMTECH - 2007, Mr. Ajay Piramal, Chairman, Nicholas Piramal Ltd., & Chairman, National Advisory Board - Pharma
2007, Dr. R.A. Mashelkar, Former Director General, CSIR and Dr. Ashok Ganguly, Chairman, First Source Solutions Ltd., Chairman
and Co-Chairman of National Innovation Board respectively, guided the event.
Dignatories at the Inaugural Function : (L to R) Mr. Nikhil Meswani, Executive Director, Reliance Industries Ltd., Mr. Ajay Piramal, Chairman, Nicholas
Piramal India Ltd., Mr. Jasu Shah, Chairman, CHEMTECH Foundation, Mrs. Satwant Reddy, Secretary, Dept. of Chemicals & Petrochemicals, Govt. of
India, Dr. Partha Ghosh, Chairman, Partha Ghosh & Associates, U.S.A., Mr. Richard Clemens, Managing Director, VDMA, Germany, Mr. Dutta Gupta,
President, ICC, Mr. Rene Van Sloten, Executive Director, Industrial Policy, CEFIC, Brussels, Mr. D.P. Misra, Director General, ICC.
8
CMYK
CMYK
INAUGURATION
The CHEMTECH + PHARMA 2007 Exhibitors Directory of the event is being released
Dignitaries on the dias during Inaugural Function
MEET OF T
IA
WORLD
Ceremonial Lamp Lighting: Respected dignitaries and guests witness the lamp lighting ceremony marking the inauguration of
the event. Mrs. Satwant Reddy, lighting the lamp. (From L to R) Dr. Partha Ghosh, Mr. Jasu Shah, Mr. Nikhil Meswani, Mr. Ajay
Piramal
9
Distinguished guests and delegates
CMYK
CMYK
WHAT EMINENT SPEAKERS SAID
CHEMTEC
007
Indian Chemical Industry has the ability to multiply
10 times from its present size.
With India
producing the highest number of scientific
graduates, we are poised to achieve higher growth
levels in future.
MR. NIKHIL MESWANI
Executive Director & Member of the Board,
Reliance Industries Ltd.
India is one of the fastest growing economies in the
world and has the potential to scale newer heights
in the EU and global markets.
MR. RICHARD CLEMENS
Managing Director , VDMA, Germany
Chemical Engineering has a strategic role to play to
reconfigure the conventional processes with new
technologies such as nano, bio, opto an info with a
higher level purpose to usher the next economic
revolution.
DR. PARTHA GHOSH
Chairman, Partha Ghosh & Associates, USA
The strong co-operation between EU and India is
on the rise. India has an enormous untapped
potential and further co-operation will be mutually
beneficial.
MR. RENE VAN SLOTEN
Executive Director, Industrial Policy, CEFIC, Brussels
10
The global conference will not only project India as
an investment destination but also as a base for
technology development and transfer. It would
give a unique opportunity for the Indian industry to
interact with their overseas counterparts in the
Pharma, Chemicals and Petrochem fileds.
MRS. SATWANT REDDY
Secretary, Dept.of Chemicals & Petrochemicals,
Govt. of India, New Delhi
The Indian Pharma Industry is making waves in
exports of generics or APIs, contract
manufacturing and R&D. Now the challenge has
shifted from using IP to creating IP. We need to
expand our R&D investment substantially to secure
our rightful place in the global arena.
MR. AJAY PIRAMAL
Chairman, Nicholas Piramal India Ltd.
Tap cheaper feedstocks abroad like for fertilizers,
we have gone to Oman and Tata has gone to
Morocco.
MR. D.P. MISRA
Director General, ICC
CHEMTECH Foundation’s new charter in the Silver
Jubilee year 2000 ‘Inspiring Intelligence … Igniting
Innovation’ has launched six initiatives to
propagate innovation – 3 in the Pharmaceutical
field and 3 in the educational field to enable
students to become leaders of tomorrow.
MR. JASU SHAH
Chairman, CHEMTECH Foundation
CMYK
CMYK
INTERNATIONAL CONFERENCES
MR. POTHEN PAUL
Managing Director, Aker Kvaerner Powergas Ltd.
The global chemical industry is witnessing a major shift from Western countries to the Asia-Pacific
as about 80-90% of expansions and new capacities are coming up in this region. The shift is
taking place because of surging economies of China and India.
India therefore has a great opportunity and has an ambitious plan to invest over US$ 20 billion in
this industry in the next few years. The country needs international co-operation for technology
transfers, joint ventures, foreign investments, strategic alliances etc.
The conference therefore deliberated on appropriate subjects like Feedstocks, Innovation,
Sustainable Growth, Global Marketing and Brand Building, Managing Competitiveness and HRD
strategies.
For sustainable growth, there are
three pillars - social, economic
and environmental value addition
with a focus on innovation.
MR. S.K. RAY
Senior Executive Vice President Polymer Business - Reliance Industries Ltd.
Chemical Engineers have a vital
role to play. We have to switch
from exploitative to enlightening
engagement with nature where
you continuously reinforce the
natural capital of the world and
make it stronger
Session on Towards Achieving Sustainable Growth, Chairman Pothen Paul (L to R) Dr. Partha Ghosh, Chairman,
Partha Ghosh & Associates, USA., Mr. Pothen Paul, Managing Director, Aker Kvaerner Powergas Ltd., Mr. S.K. Ray,
Senior Executive Vice President, Polymer Business, Reliance Industries Ltd.
MEET OF T
IA
WORLD
In India, manufacturer has to
have own infrastructure. China
provides the infrastructure like
roads, power, water, treated
effluent discharge, central
utilities, air etc. to the
manufacturer.
DR. PHARTHA GHOSH
Chairman, Phartha Ghosh & Associates, USA
11
CMYK
CMYK
CHEMTEC
007
Crude Oil derivatives and natural gas are major feed stocks for the chemicals and energy industry. With high and volatile prices of these hydrocarbons in the
global market, the future trend was discussed. Innovation in different spheres to achieve sustainable growth was also discussed.
Session on Innovation Trends. (L to R) Dr. Roland Dittmeyer, Professor, University of
Erlangen, Germany, Mr. David Seiler, Technical and Business Development Manager,
Arkema, USA
Chemical process industry will remain a core industry and
innovation is vital for its growth. Microprocess engineering,
biotechnology. transgenic plants, nano technology and
catalysis will provide the key technologies in future.
DR.ROLAND DITTEMEYER
Professor, University of Erlangen, Germany
Innovative ideas for new developments of fluoropolymers
have been developed for Chemicals & Pharmaceuticals
Industries and engineers and consultants can gainfully utilise
it as a preferred material.
MR. DAVID SEILER
Technical and Business Development Manager Arkema, U.S.A.
Energy efficiency can be increased by using a wide range
of fuels, including inferior fuels through Innovative CFBC
Technology.
12
MR. N R SHASTRY
General Manager (Marketing & Projects),
ISGEC John Thompson, Noida
Session on Feedstocks for Chemicals & Energy Chairman S. Behuria ( L to R) Mr. B.
Guha, Group General Manager, BD & JV, ONGC Ltd., Mr. S. Behuria, Chairman,
IOC, Mr. N. R. Shastry GM - Marketing & Projects, ISGEC John Thomson, Mr. A.K.
Subramanian General Manager (Proposal), ISGEC John Thomson & Mr. Nitin
Shete, Vice President R&D, Praj Industries Limited.
The growth in chemicals & petrochemicals sector
had been more than double that of India's GDP. GDP
growth of over 8% in the previous fiscal has further
boosted the growth rate of chemicals and
petrochemicals to about 15-20%.
MR. S BEHURIA, Chairman, IOC
Integrated operations capture higher values in
product chain and provide more stable revenue and
margins. ONGC, an E&P company to start with,
integrated downtrends to oil refining and with inhouse feedstocks to petrochemicals.
MR. B. GUHA
Group General Manager, BD & JV, ONGC Ltd.
Many countries including India are adopting
agrobased bio-ethanol as a transport fuel replacing
part of gasoline. It will continue as a building block
for organic chemicals and will be a preferred source
as an alternative fuel.
MR. NITIN SHETE
Vice President - R&D, Praj Industries Limited
8
CMYK
CMYK
Indian companies are increasingly establishing their
business and strategic alliances overseas to become
Indian Multinationals, to build their brands and expand
their business. This trend will continue in the coming
years.
MR. K. VENKATARAMANAN
Member of the Board & President Operations,
Larsen & Toubro Ltd.
Session on Managing Competitiveness (Panel Discussion), Chaired by Mr. K G
Ramanathan, Advisor, Reliance Industries Ltd. (L to R) Mr. J Srikant, Executive
Director, Stone Webster Rolta Ltd., Mr. Rajeev Pandia, Managing Director,
Schenectady Herdillia Ltd., Mr. K.G. Ramanathan, Mr. Pothen Paul, Managing
Director, Aker Kvaerner Powergas Ltd., Mr. D.P. Misra, Director General, ICC.
There are 10 critical issues in managing competitiveness Technology, Feedstock, Human Productivity, Operational
Efficiency, Adaptability, Financial Structure, Supply Chain
Management, how outward oriented you are and passion
for excellence.
MR. K.G. RAMANATHAN
Advisor, Reliance Industries Limited
India's image and brand has improved. Starting from a
small base, it is number one in the world in some products.
At the World Economic Forum held recently at Dovos,
there was a large Indian contingent and US clients told
that if India is not in your scheme, we can't raise money.
There are 4 strategic issues for chemical industry clusters Plant Size and Logistics, Technology, Software Culture and
Finance.
MR. AJIT SINGH,
Chairman - ACG Worldwide
MR. RAJEEV PANDIA
Managing Director, Schenectady Herdillia Ltd.
Update technology continuously, Innovate, Add value to
the user, Manage risk & liability, focus on corecompetitiveness, get rid of non-value processes and look
out for M&As for organic growth.
MR. J SRIKANT,
Executive Director, Stone Webster Rolta Ltd.
MEET OF T
IA
WORLD
Session on Global Marketing & Brand Building, Chaired by Mr. K Venkataramanan,
Member of the Board & President Operations, Larsen & Toubro Limited (L to R )
Mr. Vinod Pannamanna, Asst. Manager - Marketing, Mundra Port & SEZ Ltd., Mr. K
Venkataramanan, Mr. Ajit Singh, Chairman, ACG Worldwide
We are very good in optimizing production and
consumption but missing R&D and Innovation. Human
talent is also an acute issue. CHEMTECH's initiatives in
promoting innovation and student development are very
timely
MR. POTHEN PAUL,
Managing Director, Aker Kvaerner Powergas Ltd
13
CMYK
CMYK
CHEMTEC
007
Session on HRD Strategies for Leadership & Growth, Chaired by Mr. Z. F. Lashkari, Founder President, Yezper Consultants, (L to R) Ms. Sujata Patel, (Head Talent
Management), Larsen & Toubro Ltd., Mr. Z. F. Lashkari, Mr. Sameer Somaiya, Director, Somaiya Group & Mr.Bobby Kuriakose, General Manager, HR, Forbes Marshall
CHEMTECH's initiative of a study group 'Students Academia - Industry' interaction to prepare leaders of
tomorrow has begun and will accelerate in future.
MR. Z. F. LASHKARI
Founder President, Yezper Consultants
Continuously assessing availability of talent in the
organization and strategizing for key development
initiatives as well as ensuring the talent pipeline is well
filled by sourcing from external market, is a dual role that
organizations need to play continuously.
MS. SUJATA PATEL
Head - Talent Management, Larsen & Toubro Ltd.
Creating a great place to work is the key to nurturing and
retaining talent.
MR. BOBBY KURIAKOSE
General Manager - HR, Forbes Marshall
For HRD, rural area consists of 70% and talents in the area
should be identified and nurtured. Opportunities must
then be provided for them for the overall economic Growth
of the country.
MR. SAMEER SOMAIYA
Director, Somaiya Group
14
8
CMYK
CMYK
WORLD EXPO
2007
The Panel discussion centered on "Water Management" in industry and urban areas. The
increasing demand supply gap of water in India and many parts of the world and flooding of
urban areas during monsoon were covered. A number of suggestions were evolved at the end
of the Panel Discussion.
MR. AJAY POPAT
CEO, Ion Exchange Waterleau
Water consumption can be
reduced by 40-90% in industries,
10-15% in agriculture and 3035% in Urban Sectors. There is
no dearth of technologies in India.
MR. YOGEN PARIKH
Associate Director,
Environmental Engineering,
Jacobs Engineering India Pvt. Ltd.
Self motivation is required for
dealing with environmental
issues. Think socially and act
individually.
Round Table Discussion on Water Management in India - Mr. Yogen Parikh, Associate Director Environmental
Engineering, Jacobs H&G Pvt. Ltd., giving his point of view
MEET OF T
IA
WORLD
Water is a vital resource. There
are stringent regulations and
enforcement and incentives on
consumption and discharge.
Increased public awareness and
litigations are, however, required
for total water management.
MR. SOLI ARCEIWALA
15
CMYK
CMYK
CHEMTEC
007
CHINA & GERMAN DAY SEMINAR 2007
China Day Seminar
From L-R: Mr. Tang Yue, Ms. Wang Yajun, Deputy Vice Secretary, China Association for Pharmaceutical Eqipment, Mr. Chen Husheng, Director,
Shang Hai Far-East Pharmaceutical Machinery General Factory, Mr. Gao Chuan, General Manager, Hei Longjiang Dier Pharmaceutical
Machinery Co. Ltd., Mr. Subodh Pirolkar, Mr. Jiao Zede, General Manager, Beijing Aerospace Wanda Hi-tech Development Center, Mr. Zhao Lin,
Deputy Vice Secretary, China Association for Pharmaceutical Eqipment
CHEMTECH in collaboration with the China Association for Pharmaceutical Equipment (CAPE) had organized an exclusive half-day networking session on Feb 6th. Mr.
Chen Husheng, Director, Shanghai Far-East Pharmaceutical Machinery Factory and Vice-President, CAPE started the meeting with a presentation introducing the
China Pharmaceutical Equipment Industry and major players. Mr. Subodh Priolkar, President Indian Pharmaceutical Association (IPA) and Director, Valois India Pvt.
Ltd, presented an “Overview of the Indian Pharmaceutical Industry”. There was a round of interactive discussions between the audience and Chinese exporters from
different enterprises, followed by one-to-one business meetings.
German Day Seminar
Latest German technology for the Chemical and Pharmaceutical Industry
On February 7th, CHEMTECH, in collaboration with Federation of German Engineering
Industries VDMA, organized an exclusive halfday technical Symposium featuring the latest
German technology for the Chemical and Pharmaceutical Industry.
Dr. Alexander Koldau, VDMA, Germany listens while Mr.
M. Metin Gerceker of Linde AG Engineering Division
presents a Case Study on “High Performance Butterfly
Valves for Petrochemical Application”.
The Symposium started with the Welcome Address by Mr Ajit Singh, Chairman, ACG Worldwide. Dr Alexander
Koldau of VDMA, (Fachverband Verfahrenstechnische Maschinen und Apparate, a German Engineering
Federation) welcomed the audience on behalf of Mr Richard Clemens, VDMA. This was followed by the Opening
Remarks by Mr Clemens.
The Technical Sessions started with a presentation on “New Economical Perspective Through Multisafe Process Pumps with Online Diagnosis by Mr Heinz M.
Nägel, FELUWA Pumpen GmbH. Mr. M. Metin Gerceker, Linde AG Engineering Division followed with a Case Study on “High Performance Butterfly Valves for
Petrochemical Application”.Mr Manfred Kluge, Richter Chemie Technik GmbH gave a presentation on “Process Pumps and Valves for Highly Corrosive Fluids”.
Mr Sunil Mehta, Nord Drivesystems P Ltd. gave an overview on “The Current Scenario and the Future Challenges for Drive Systems in the Pharma and Chemical
Industry” Mr Gerhard Kegli, Chetra GmbH spoke on “The Importance of Mechanical Seals for Functioning Rotating Process Equipment” while Franz Fähler,
Pharmatest GmbH made a presentation on “Tablet Dissolution Testing Official Requirements and Solutions”.
16
The technical symposium drew a very select audience and VDMA officials were very satisfied with the response.
8
CMYK
CMYK
The Indian pharmaceutical industry has of one of the highest growth rates in the world today. The industry has also made the transition from low-cost bulk drug
makers into global leaders in custom synthesis. Investments in R&D has also increased and Indian pharma companies are acquiring a global identity as they
acquire companies or collaborate with MNCs.
MEET OF T
IA
WORLD
Release of Frost & Sullivan Report. (L to R) Mr. Ajit Dangi, Director General, OPPI, Ms. Jayashri Kulkarni, Director, Health Care Practice, Frost &
Sullivan, Mr. Ajay Piramal, Chairman, Nicholas Piramal Ltd., (releasing the report), Mr. Ranjit Shahani, President, OPPI & Vice Chairman & MD,
Novartis India Ltd., Mr. Chris Nagel, V.P. (Operations, Asia & Singapore), Jacobs Engineering, Singapore.
The PHARMA International Conference 2007 captured glimpses of the many achievements of the Indian pharma industry. Global industry leaders also spoke
on their experiences in this buoyant sector and highlighted the fact that many MNCs are coming to India hoping to meet future growth projections.
The exclusive report prepared by Frost & Sullivan for CHEMTECH Foundation, titled, "Indian Pharma Industry - Strategies For Sustainable Growth &
Leadership" focused on the winning strategies of the Indian pharma industry.
17
CMYK
CMYK
CHEMTEC
007
Opening Session of PHARMA 2007 International Conference, Chaired by Mr. Ajay Piramal, Chairman, Nicholas Piramal Ltd.(L to R) Mr. Ajit Dangi, Director General, OPPI, Ms. Jayashri Kulkarni, Director,
Health Care Practice, Frost & Sullivan, Mr. Ajay Piramal, Mr. Ranjit Shahani, President, OPPI & Vice Chairman & MD, Novartis India Ltd., Mr. Chris Nagel, V.P. (Operations, Asia & Singapore), Jacobs
Engineering, Singapore., Ilan Kreiser, Chairman, Pharmaceutical Society of Israel.
India's pharmaceutical industry has done well for itself.
India has become a source not just for APIs, but also for
finished formulations, research activities and services. The
Indian market is expected to grow at 12% annually making
us the second fastest growing economy in the world.
MR. AJAY PIRAMAL
Chairman, Nicholas Piramal India Ltd.
The major marketing task of any pharmaceutical
company is building a trustful and appreciative
relationship with customers. Pharmaceutical companies
can do this using the innovative practice of
communicating knowledge to acquire and maintain longlasting trust and good will of health practioners.
18
MR ILAN KRIESER
Chairman, The Pharmaceutical Society of Israel
President, Kreiser Medical Ltd., Israel
For CRAMS or mainstream marketing, the dynamic
pharmaceutical landscape necessitates rapid response to
transit to the next phase of growth which can be achieved
via the options of M&As and/or networking leadership.
MS JAYASHRI KULKARNI
Director, Health Care Practice, Frost & Sullivan
In the 18th century, India had close to 24% of global GDP
followed by China (22%) and Europe (20%). If the 19th
century belonged to Britain, the 20th century to the USA, it
is our hope that the 21st century, will belong to India and
China ….Our dream is to move from 'MADE IN INDIA' to
'INVENTED IN INDIA.
MR RANJIT SHAHANI
President, OPPI & Vice Chairman & MD, Novartis India Limited.
CMYK
CMYK
The Indian pharma industry is in a paradigm shift from a
destination for clinical trials and low-IP sensitive discovery
chemistry … to a destination offering high-value services
and partnering opportunities.
MR. AJAY MUTTREJA
Tecnova India Pvt Ltd, Haryana
Session on Technology Trends - Recent Advances (L to R) Mr. Bruno Stoltz, GMM Pfaudler Werke
GmbH, Germany, Mr. Bapu Saheb Patil, Managing Director, BASP Industries, Mr. Rudiger
Froehning, Managing Director (Exports), Al-Ko Therm GmbH, Germany, Mr. Michael Casey,
Operations Director, SNC Lavalin, Intl Engineering Consultant, India/Canada, Dr. Justin O Neway,
Executive Vice President & Chief Science Officer, Aegis Analytical Corporation, USA.
The US FDA's new regulatory framework and Process
Analytical Technology (PAT) is aimed at encouraging the
use of innovative technologies in pharma and biotech
process development and manufacturing. Companies
that move towards the science-based process
understanding will benefit from "regulatory flexibility".
DR JUSTIN O NEWAY
Executive Vice President & Chief Science Officer, Aegis Analytical Corporation
Although India has adopted the new patent regime in
2005, it still has a long way to go in terms of improving its
overall pharmaceutical IP environment to meet the
standards of developed countries. As India seeks to climbup the innovation chain, it must develop a robust R&D
industry in addition to its generic capabilities.
MR DAVID GOREN
Head of Global Strategic Planning, Pfizer, USA
The JETT Consortium helps the streamlining of equipment
acquisition and qualification through application of
GAMP principles. It is found that the business
performance of respondents, who had better regulatory
awareness and knowledge and were more skilled at
applying those regulations, was higher than their
expectations.
MEET OF T
IA
WORLD
Session on Opportunities & Strategies, Chaired by Mr. Jagdish Saxena, CMD, Elder
Pharmaceuticals Ltd. (L to R) Mr. David Goren, Head of Global Strategic Planning, Pfizer, USA., Mr.
Jagdish Saxena, Mr. Ajay Muttreja, Tecnova India Pvt. Ltd., Dr. Praful Naik, Chief Scientific Officer,
Bilcare Ltd.
MR MICHEAL CASEY
Operations Director, SNC Lavalin, International Engineering Consultant
19
CMYK
CMYK
biotech
WORLD EXPO
2007
The World biotechnology industry completed 30 years in 2006. Though India was a late starter in modern biotechnology, it is rapidly picking up because or rich
biodiversity, world-class research laboratories, availability of scientists, extensive knowledge base, entrepreneurship, access to vast and diverse disease
populations and a strong support from the government.
CHEMTEC
007
Demand for innovation drugs to combat the existing and new types of diseases is leading to increased demand for biotech drugs worldwide. With India's
strengths, the country aims to be amongst the top 5 countries in the biotech field.
The Biotech 2007 International Conference discussed various issues like International Partnership, Opportunities, Recent Developments, Emerging Legal Issues
and Nanobiotech, which drives innovation in healthcare.
Opening Session of BIOTECH 2007 International Conference (L-R) Mr. Anil Mazumdar, Senior
Advisor, Chemtech Foundation, Dr. Partha Ghosh, Chairman, Partha Ghosh & Associates, USA, Mr.
Utkarsh Palnitkar, Director, Ernst & Young
The convergence of several powerful technologies
like biotech, nanotech and infotech open us to a
universe of infinite knowledge, which, for the first
time, will empower mankind to enrich the ecological
balance and beauty of nature and in turn open up
infinite possibilities to offset the limits of finite
resources.
Session on International Partnerships, Chaired by Dr. Swati Piramal, Director, Strategic
Alliances & Communications, Nicholas Piramal Ltd. (L to R) Mr. Anil Mazumdar, Mr. Sanjeev
Saxena, Chairman, ACTIS Biologics Inc. California, USA, Dr. Swati Piramal, Dr. Lynne Parker,
Managing Partner, Amer Asia Venture Advisor, LLC, New York.
The clue to “smart alliances” in the new globalized scenario is to
become the partner of choice. The idea at NPIL is to leverage
core competencies, to use strategic alliances as a tool to leapfrog
over competitors.
DR SWATI PIRAMAL,
Director, Strategic Communications & Alliances,
Nicholas Piramal India Limited, Mumbai
DR. PARTHA GHOSH
Chairman, Partha Ghosh & Associates, USA
We have to create a business standard which is
sensitive to and supportive of the needs of
biotech companies. This is the way to foster
entrepreneurship in the biotech industry. We
also need to develop a single unified voice for
the Indian biotech industry.
20
MR. UTKARSH PALNITKAR,
Director, E&Y, Hyderabad
Most US, European and Japanese companies have specialized
departments to find cutting-edge, innovation life science
technologies at earlier stages and several have venture capital
affiliates to find, evaluate, acquire and invest in such companies.
With the advent of stronger IP levels, this trend is expected to
spread in India.
DR. LYNNE H PARKER
Managing Partner, Amer Asia Venmture Advisor LLC, New York
CMYK
CMYK
biotech
WORLD EXPO
2007
THE ERNST & YOUNG REPORT
Session on Opportunities in Biotech Sector Infrastructure and Finance - ( L to R) Mr. Anil
Mazumdar, Senior Advisor, Chemtech Foundation, Dr. Marteen V Dougen, Partner, InnoTact
Consulting BV, Netherlands, Mr. Jaideep Iyer, Sr. Vice President, Dept. of Life Science &
Technology, YES Bank Ltd., Mr. Sandesh Seth, Managing Director, Amer Asia Capital Partners,
LLC, New York.
Private equity, Venture Capital and pledge funds from US and
EU are looking overseas for opportunities in alternative
financial strategies, which include SPACs (Special Purpose
Acquisition Companies), RIPO-PIPEs (Reverse IPO with a
Private Placement in Public Equity), private IPOs are listing on
London, Dubai and Hongkong exchanges. Indian firms
should learn such markets and take advantage.
MR. SANDESH SETH
Managing Partner, Amer Asia Capital Partners, LLC New York
We are really impressed by India and we should nurture
India
DR. MARTEEN V DOUGEN
Partner, InnoTact Consulting BV, Netherlands
Funding opportunities at the early stage of biotech
ventures has been difficult but if we draw a parallel
between the IT and biotech industries, the IT industry also
went through this phase and is now getting funds even at
early stages. So we are sure that early stage funding of
biotech ventures will also pick up soon.
MR. JAIDEEP IYER,
Sr. Vice President, Dept. of Life Science & Technology, YES Bank Ltd.
Session on Recent Developments in Bio-Pharmaceuticals (L to R) Mr. Erik Torseke, GM ITT,
Monitoring & Control Inc. U.S.A., Dr. S.D. Ravetkar, Sr. Director, Serum Institute of India, Mr.
Hariprasad Manavalan, Industry Manager (Pharma & Biotech), Endress+Hauser (India) Pvt. Ltd.
Recent trends in biopharmaceuticals is a shift to the
development of hormonal and growth factor
biopharmaceuticals from the earlier base of blood factors,
anti-coagulants, thrombolytics, interferons, interlankins
and recombinant vaccines.
DR. SATISH RAVETKAR
Sr. Director, Serum Institute of India
MEET OF T
IA
WORLD
Ernst & Young, as Knowledge partner, prepared a report
"The Indian Biotech Industry - 7 steps to Glory"
exclusively for this event. It was released in the opening
session.
New technologies like in-plant wireless communication,
MEMS based vibration sensors, web based user interfaces
etc. can provide a cost effective protection of plant
equipment.
MR. ERIK TORSEKE
General Manager, ITT Monitoring & Control Inc. USA
21
CMYK
CMYK
biotech
CHEMTEC
007
WORLD EXPO
Session on Emerging Legal Issues, Chaired by Dr. Prabuddha Ganguly, CEO,
Vision-IPR, (L to R) Mr. Anil Mazumdar, Mr. Dominic Keating, First Secretary for
Intellectual Property, Embassy of the United States of America, Dr. Prabuddha
Ganguly, Mr. Suhail Nathani, Partner, Economics Law Practice, Dr. Arun Bhatt,
CEO, Clininvent Research.
Session on Nano-Biotech Driving Innovation in Health Care (L to R) Dr. S Ahmed,
Vice Chancellor, Hamdard University & Former Director of Central Electronics
Engineering Research Institute, Dr. Pawan Saharan, Chairman & CEO, Biomix
Network Inc. USA., Dr. Roberto Raiteri, Director, Nanotechnology Centre,
University of Genova, Italy.
India has become a new destination for Clinical Research
Outsourcing (CRO), leading to the rise of many Indian
CROs. Bioethics is an important CRO function as defined
in GCP guidelines. Indian CROs and sponsors have to
work together to resolve the bioethical challenges.
Molecular recognition combined with self-assembled
monolayer technique is going to play a dominant role in
future development of high sensitivity, high selectivity and
low cost biosensors for progressively increasing the
number of applications.
DR. ARUN BHATT
CEO, Clininvent Research, Mumbai
DR. S. AHMED
Vice Chancellor, Hamdard University & Former Director of
Central Electronics Engineering Research Institute
Biotechnology is an area where many technologies have
merged and it is at this interface that we are confronted
with many emerging issues. It is very important that we
address these issues as they have profound implications
on human rights, privacy, ethical controls, etc. The future
is going to be very alive to debates of this kind.
DR. PRABUDDHA GANGULY
CEO, Vision-IPR, Mumbai
With biological/genetic resources, it is sometimes
difficult for an inventor/researcher to accurately track
down the source of the biological matter in the
invention. The debate on this continues.
MR. DOMINIC KEATING
First Secretary of Intellectual Property,
Embassy of the United States of America, New Delhi
22
2007
A new family of sensors based on mechanical
deformations of nano-structures has attracted a lot of
interest at the academic and industrial level to develop
new sensing devices with unique charecteristics in terms of
sensitivity, miniaturisation, simplicity of use and costs.
DR. ROBERTO RAITERI
Director, Nanotechnology Centre, University of Genova, Italy
Nano-biotechnology, the Science of 21st Century will
revolutionize the global economy and will act as a
fundamental driver of change. Convergence of
nanotechnology with biotechnology will produce hightech products at low cost.
DR. PAWAN SAHARAN
Chairman & CEO, Biomix Network Inc. USA
CMYK
CMYK
CLINICAL Research 2007
MR. SWAMINATHAN AIYER
Consulting Editor, The Economic Times
Today, more than 40% of clinical trails are conducted in developing nations. It is estimated that by
2010, global pharma majors would spend around $1-1.5 billion on clinical trials in India. This
would mean that the clinical trial industry is doubling in revenue every 2 years. The question is, can
the Indian clinical research industry cope with these growth rates? Industry professionals are
faced with the task of upgrading quickly to global standards. In response to this need, CHEMTECH
launched The Indian Forum for Good Clinical Practice (InFo-GCP) at CHEMTECH 2005. The
objective of this initiative was to propagate GCP awareness and excellence in clinical research.
The CLINICAL RESEARCH International Conference 2007 marked another milestone in this
journey towards making India a high-quality destination for clinical trials. Eminent speakers dealt
with important issues affecting the clinical research industry like Business and Investment
Opportunities, Ethical and Regulatory Barriers in Clinical Research, Capacity Building measures
to develop clinical research professionals, and creating Centres of Clinical Excellence.
Clinical research industry has been
identified as an "opportunity area"
and it is recognized that India has
strengths and capabilities to
become a key global player.
MR. VISHAL GANDHI
Asst Vice President, Life Sciences &
Technology Practice, YES Bank
There is an increased responsibility
on Indian clinical r esear ch
stakeholders … to continuously
define and improve quality and
enhance our "audit worthiness
assurance" to make India a quality
destination for global clinical
research.
DR. DHANANJAY BAKHLE
Senior Director, Medical & Regulatory Affairs,
sanofi-aventis, India, and Convener of
CHEMTECH Foundation's initiative,
Indian Form for Good Clinical Practice (InfoGCP)
MEET OF T
IA
WORLD
There is a strong moral case for
undertaking clinical trials in India
because they extend health benefits
to trial participants, help reduce
global costs of developing new
drugs, and make better medicines
available to many, saving lives all
over the world.
Session on Business and Investment Opportunities, Chaired by Dr. Dhananjay Bakhle, Senior Director, Medical &
Regulatory Affiars, Sanofi-aventis, & Convenor, Indian Forum for Good Clinical Practice (InFoGCP),(L to R) Ms. Susan
Trainor, European Forum for Good Clinical Practice (EFGCP), President & COO Trainor & Partners, Dr. Dhananjay Bakhle,
Mr. Jasu Shah, Mr. Humayun Dhanrajgir, Chairman, Emcure Pharmaceuticals Ltd., Mr. Vishal Gandhi, Asst. Vice
President, Life Science & Tech. Practice, YES Bank Ltd.
23
CMYK
CMYK
CHEMTEC
007
Session on Addressing Ethical & Regulatory Barriers (L to R) Ms. Susan Trainor, European
Forum for Good Clinical Practice (EFGCP), President & COO Trainor & Partners, Dr. Narges
Mahaluxmivala, President Clinical Services & Commercialization, Quintiles Research (India)
private Ltd., Mumbai.
Session on Capacity Building (L to R) Dr. John Hooper, Chief Executive, The Institute of
Clinical Research, U.K., Dr. Vis. Niranjan, CEO, RxMD, Chennai, Dr. Sanjay Bettadpura,
Manager Life Sciences Practice, Edutech India Pvt. Ltd., Dr. Pranay Lal, Project Director,
Political Advocacy, International AIDS Vaccine Initiative (IAVI), New Delhi.
We need to think beyond the GCP text by finding new
practical ways to apply them … India is blessed with a
population of intellects, artists, technicians, who can assist
the research community in applying the GCP guidelines in
a more creative way when dealing with the vulnerable
(subject) population. And I think this is an important way to
show the world that India has no intention of conducting
business without ethics.
If India desires to achieve global standards, it needs to
develop global quality professionals, and prepare them
with theoretical as well as practical training.
MS. SUSAN TRAINOR,
European Forum for Good Clinical Practice (EFGCP)
Differences in ethical understanding do not mean lower
ethical standards. Country and cultural perspectives must
be considered when ethical standards are judged.
DR. NARGES MAHALUXMIVALA
President-Clinical Services & Commercialization, Quintiles India
DR. JOHN HOOPER
Chief Executive, Institute of Clinical Research, UK
The key constraints in AIDS vaccine research in India are
policy and governance issues such as inadequate funding,
lack of priority, no road maps, and market related
challenges. The last can be probably addressed by "pull
mechanisms" such as market guarantees, IPR incentives,
tax breaks on sales etc.
MR. PRANAY LAL
Project Director, Political Advocacy,
International AIDS Vaccine Initiative (IAVI), New Delhi
24
CMYK
CMYK
India has tremendous advantage in the Knowledge
Process Outsourcing (KPO) sector. In the clinical research
sector, this could be in the areas of consulting, clinical
operations, data management, drug safety, biostatistics
and medical writing. We need to build knowledge pools to
offer these services to global clients.
DR. VIS NIRANJAN
CEO, RxMD, USA
There is a metamorphosis of a clinician into an
investigator. Today a modern day clinician-researcher is
vital to the continued progress of medical therapy.
DR. MOHAN BADGANDI
Consultant in Diabetes, Endocrinology and Obesity,
Manipal Hospital, Bangalore
A Clinical trial is a team game. It is important to form a
great team and find the right person for the right task.
Honesty and Integrity are paramount and most
importantly, the welfare of the patient is top priority.
DR. M. K. RAMESH
Associate Professor - Department of Surgery,
Bangalore Medical College and Victoria Hospital, Bangalore
Effective communication with potential patients,
community at large, healthcare-workers and the media
led to a successful outcome in the recent AIDS vaccine
trial undertaken by us at NARI
MEET OF T
IA
WORLD
Session on Centres of Clinical Excellence (L to R) Dr. Vis. Niranjan, CEO, RxMD, Dr. Sanjay Mehendale, Deputy Director, National AIDS Research Institute (Indian Council of Medical
Research), Dr. Mohan Badgandi, Consultant in Diabetes, Endocrinology and Obesity, Manipal Hospital
DR. SANJAY MEHENDALE
Deputy Director, National AIDS Research Institute, Pune
25
CMYK
CMYK
THE CHEMTECH-CEW + PHARMA-BIO AWARDS 2007
CHEMTEC
007
CHEMTECH Leadership and Excellence Awards are conferred on deserving luminaries
in different categories at all International Events held by CHEMTECH. An eminent
panel of judges selects these prestigious awards after discussing various nominations
received by CHEMTECH.
For the 2007 Awards, the panels were chaired by Mr. K.G. Ramanathan, Advisor,
Reliance Industries Ltd., for CHEMTECH 2007 Awards and Mr. Ajay Piramal,
Chairman, Nicholas Piramal India Ltd. and Chairman, National Advisory Board Pharma for Pharma-Bio Awards. The Awards were distributed by Mr. Laxman Prasad,
Advisor, Dept. of Science & Technology.
The Roll of Honour
CHEMTECH AWARDS
Hall of Fame :
Mr. Karsan Bhai Patel,
Chairman, Nirma Ltd.
Business Leaders of the Year :
Mr. Rajju Shroff,
Chairman & Managing Director, United Phosphorus Ltd.
(Chemicals)
Dr. Michael Thiemann,
Vice Chairman & Managing Director, Uhde India Ltd
(Engineering Services)
Mr. Sidharth Raj Luthra,
Managing Director, Sukhras Machines Pvt. Ltd. (Engineering)
Outstanding Contribution
Prof. Ashok Misra,
Director, IIT, Mumbai. (Education)
Mr. Pramod Chaudhari,
Chairman, Praj Industries Ltd. (Innovation)
Outstanding Achievement (R & D))
Prof. G. D. Yadav, Professor, UICT
Dr. P. K. Ghosh, Director, CSMCRI.
PHARMA AWARDS
Mr. Jasu Shah presents a bouquet as token of love to Dr. Laxman Prasad
Sharma, Advisor, Dept. Of Science & Technology.
Business Leader Of The Year
Mr. Dilip S Sanghvi,
Chairman & Managing Director,
Sun Pharmaceutical Industries Ltd. (Pharma)
Dr. Cyrus Poonawala,
Chairman & Managing Director, Serum Institute of India (Biotech)
Outstanding Achievement(R&D)
Mr. Glenn Saldhana,
Managing Director & CEO,
Glenmark Pharmaceuticals Ltd. (Corporate)
Dr. J. S. Yadav,
Director, Indian Institute of Chemical Technology (Institution)
Dr. (Mrs.) Swati Piramal,
26
Director Strategic Alliances & Communication,
Nicholas Piramal Ltd. (Pharma + Biotech)
In honour of the best: Mr.
Jasu Shah, Chairman ,
CHEMTECH Foundation,
delves upon the criteria for
selecting the awardees
Mr. Aasif Khan,
Managing Director,
Fabtech Technologies International Pvt. Ltd. (Engineering)
A large gathering of distinguished guests attend the ceremony to applaud the felicitation
of the chosen industry leaders
CMYK
CMYK
CHEMTECH CEW AWARDS 2007
(Education)
Hall Of Fame
Prof. Ashok Misra
Director, IIT, Mumbai
(CHEMICALS)
(Innovation)
Mr. Rajju Shroff
United Phosphorus Ltd.
Mr. Pramod Chaudhari
Chairman,
Praj Industries Ltd.
(Engineering Services)
Dr. Michael Thiemann
Vice Chairman &
Managing Director,
Uhde India Ltd
Outstanding Achievement
(R&D)
Prof. G. D. Yadav
Professor, UICT
(Engineering)
Outstanding Achievement
(R&D)
Mr. Sidharth Raj Luthra
Managing Director,
Sukhras Machines Pvt. Ltd.
Dr. P. K. Ghosh
Director, CSMCRI.
MEET OF T
IA
WORLD
Mr. Karsan Bhai Patel
Chairman, Nirma Ltd.
27
CMYK
CMYK
CHEMTEC
007
PHARMA - BIO AWARDS 2007
(PHARMA)
(Institution)
Mr. Dilip S Sanghvi
Sun Pharmaceutical Industries Ltd.
Dr. J. S. Yadav
Director,
Indian Institute of Chemical
Technology
(Pharma+Biotech)
(Biotech)
Dr. (Mrs.) Swati Piramal
Director Strategic Alliances &
Communication,
Nicholas Piramal Ltd.
Dr. Cyrus Poonawala
Serum Institute of India
(corporate)
Mr. Glenn Saldhana
Managing Director & CEO,
Glenmark Pharmaceuticals Ltd.
(engineering)
Mr. Aasif Khan
Managing Director,
Fabtech Technologies
International Pvt. Ltd.
28
CMYK
CMYK
THE CHEMTECH-CEW + PHARMA-BIO AWARDS 2007
MEET OF T
IA
WORLD
Best of the Best : Awardees of the
CHEMTECH + PHARMABIO Awards 2007
29
CMYK
CMYK
International delegations forge new ties
CHEMTEC
007
Delegates from more than 22 countries participated in CHEMTECH World Expo and attended specialised buyer-seller meets. In
addition, seminars like the 'German Technical Symposium”, 'CAPE China Day' and the 'Italian Day' were held. These meets saw a lot of
interaction between exhibitors and delegates and the beginning of many collaborations.
CHEMTECH had also organized plant visits for delegations from Thailand and China. The sites visited included the Nicholas Piramal
Research Centre, manufacturing plants of Glenmark Pharmaceuticals Ltd, Elder Pharmaceutical Industries Ltd, Indoco Remedies,
Associated Capsules Pvt Ltd and Consite Engineering Co Ltd.
Thai Delegation visiting the plant of Elder Pharmaceuticals Ltd., Mumbai
Italian Press Conference
During the PHARMA + BIOTECH World Expo 2007 Event, Italy held après Conference on “Italian Packaging and the Pharmaceutical
Industry & Pharmintech 2007” on February 9, 2007.
Mr. Guido Corbella, CEO, Ipack – Ima Spa, Milan, Italy, speaking on the occasion, highlighted the role of Italy as one of the World’s leading
producers of Packaging equipment, 88% of which is exported. Italy’s strengths are advanced technology, adaptability and customer
orientation. Italy, he said, enjoys 25% share of European market, 19% in the Americans, number one supplier in Oceania and Africa and a
leading supplier in Hongkong, Taiwan, India and Turkey.
He invited the Indian Pharmaceutical Industry to visit Pharmintech 2007 event at Bologna, Italy in June 2007. The event, organized by Ipack-Ima, will showcase
the latest technologies in packaging.
30
Mr. B. S. Kampano, Chairman, Indian Institute of Packaging and Dr. P. G. Shrotriya, Member of the Indian Pharmacopoeia Commission and Chairman of
Parenteral Products Committee were the guests at the Conference
CMYK
CMYK
Main Entrance of the Exhibitions
Inauguration of the Exhibition by Mrs. Satwant Reddy, Secretary, Dept.of
Chemicals & Petrochemicals, Govt. of India, New Delhi
Sponsors & Supports of the Events
SILVER : GAIL (INDIA) LTD.
PRINCIPAL : RELIANCE INDUSTRIES LIMITED
SUPPORT : MAHARASHTRA INDUSTRIAL DEVELOPMENT CORPORATION
MEET OF T
IA
WORLD
Apart from stalls by overseas countries,
a number of Indian companies displayed
their expertise in products, processes
and services.
Totally some 600
companies participated in the
Exhibition, which was the largest one
held so far by CHEMTECH. Visitors
from over 50 countries evinced keen
interest in Indian stalls.
31
SUPPORT : OIL AND NATURAL GAS CORPORATION LTD.
SUPPORT : BHARAT PETROLEUM CORPORATION LTD.
HOSPITALITY : INDIAN OIL CORPORATION LTD.
CMYK
CMYK
International Pavilions
CHEMTEC
007
German Pavilion
LINDE ENGINEERING
GEA ECOFLEX GMBH
ROCHLING ENGINEERING PLASTICS
NORD DRIVE SYSTEMS PVT. LTD
SHANGHAI RITAI MEDICINE EQUIPMENT PROJECT CO. LTD
CHINA ASSOCIATION FOR PHARMACEUTICAL EQUIPMENT
SHANGHAI NEW XUFA MACHINE S&T CO. LTD
SHANGHAI TOFFLON SCIENCE AND TECHNOLOGY CO. LTD
DE - DIETRICH PROCESS SYSTEMS
COREAU
KMPT AG
China Pavilion
ZHEJIANG FUCHANG MACHINERY CO. LTD
French Pavilion
32
CMYK
CMYK
Innovative Products Display
ALFA LAVAL (I) LTD
GMM PFAUDLER LTD
SUKHRAS MACHINES PVT. LTD
KHOSLA PROFIL PVT. LTD
SWISS GLASCOAT EQUIPMENTS PVT. LTD
TITANIUM TANTALUM PRODUCTS LIMITED
DINSHAW FILTRATION SYSTEMS PVT. LTD
PENNWALT LTD
DALAL ENGINEERING PVT. LTD
SYSTEMS AND COMPONENTS (I) PVT. LTD
D. PARIKH ENGINEERING WORKS
MEET OF T
IA
WORLD
BASP INDUSTRIES
33
CMYK
CMYK
CHEMTEC
007
Chemical & Pharma Process Equipments Companies
GOEL SCIENTIFIC GLASS WORKS (P) LTD
THERMOTECH ENGINEERING
BIFRIENDS ENGINEERING WORKS
PRAJ INDUSTRIES LIMITED
PENNWALT LTD
JOFLO CENTRIFUGES PRIVATE LIMITED
ACE INDUSTRIES
HEMRAJ ENTERPRISES
IDMC LIMITED
SUPER SCIENTIFIC WORKS P. LTD
SHARPLEX FILTERS( INDIA) PVT. LTD
PREMIUM ENERGY TRANSMISSION LTD
34
ORIENTAL MANUFACTURERS PVT. LTD
CMYK
CMYK
New Technology Launch
CHEMFILT
HRS PROCESS SYSTEMS PVT. LTD
AIROX NIGEN EQUIPMENTS PVT.LTD
OMEGA - KEMIX PVT . LTD
ACMEFIL ENGINEERING SYSTEMS PVT. LTD
CHEMOFAB INDUSTRIES
CONSITE ENGINEERING COMPANY LTD
K-JHIL SCIENTIFIC GLASS
MEET OF T
IA
WORLD
HI- TECH PHARMA EQUIPMENTS
RAJ PROCESS EQUIPMENT & SYSTEMS (P) LTD
35
DIPESH ENGINEERING WORKS
SUPER SCIENTIFIC WORKS P. LTD
INOXPA TRADING INTERNATIONAL S.L.
CMYK
CMYK
CHEMTEC
007
Pumps & Valves Manufacturing Companies
JEE PUMPS (GUJ.) PVT. LTD
SHREE GANESH ENGINEERING LTD.
ECONOMY REFRIGERATION LTD
ORBINOX INDIA PVT. LTD
ITT CORPORATION
FLOVEL VALVES PVT.LTD
KIRLOSKAR BROTHERS LIMITED
HAWA VALVES (INDIA) PVT.LTD
GRUNDFOS PUMPS (I) PVT.LTD
UNP POLYVALVES (INDIA)PVT. LTD
KISHOR PUMPS PVT LTD
ANTICORROSIVE EQUIPMENT PVT. LTD.
36
GLYNWED PIPE SYSTEMS (I) LTD
CMYK
CMYK
Pharma Companies
NIRO PHARMA SYSTEMS C/O.GEA PROCESS ENGINEERING (INDIA) LTD
ACG WORLD WIDE
SARTORIUS INDIA GROUP
BECKER TECHNOLOGIES PVT. LTD
KLENZAIDS CONTAMINATION CONTROLS PVT. LTD
SQUARE PHARMA MACHINERIES
RAPID PACK ENGINEERING PVT. LTD
PARLE PHARMA MACHINERIES
MEET OF T
IA
WORLD
ELECTROLAB
FILTRA TEKNOPAK CLEAN ROOM SYSTEMS PVT. LTD
37
BOSCH (MOTOR INDUSTRIES COMPANY. LTD)
FETTE COMPACTING INDIA
ELDER PHARMACEUTICAL LTD
CMYK
CMYK
CHEMTEC
007
Automation Companies
CHEMTROLS ENGINEERING LTD
GANDHI ENTRANCE AUTOMATIONS PVT. LTD
ROTEX AUTOMATION LTD
RADIX MICROSYSTEMS
BARTEC GMBH
HAWA ENGINEERS LTD.
ANM ALLIANCE
TESTO INDIA PVT. LTD
EXOR INDIA PVT. LTD
MAGNETROL INTERNATIONAL INC
ROLTA INDIA LTD.
ENDRESS + HAUSER (INDIA) PVT. LTD
38
B & R INDUSTRIAL AUTOMATION PVT. LTD
CMYK
CMYK
Science, Technology & Innovation
COUNCIL OF SCIENTIFIC INDUSTRIAL & RESEARCH
DOSHI ION LIMITED
WAM BOMBAY B.H.E.I PVT. LTD
ION EXCHANGE (INDIA) LTD
IDEX INDIA - FLUID & METERING TECHNOLOGIES
MINISTRY OF EARTH SCIENCES GOVT. OF INDIA
SGL CARBON INDIA PVT. LTD
NETEL (INDIA) LIMITED
MEET OF T
IA
WORLD
DEPARTMENT OF SCIENCE & TECHNOLOGY (DST)
BONFIGLIOLI TRANSMISSIONS P. LTD
39
TRANTER INDIA PVT. LTD.
COLE -PARMER INDIA
FORBES MARSHALL
CMYK
CMYK
CHEMTEC
007
Other Exhibitors
HYDROPURE SYSTEM
CLEAR EDGE FILTRATION INDIA PVT.LTD
KEVIN ENTERPRISES PVT. LTD
PRAKASH STEELAGE LIMITED
FILTER MEDIA
KORES (INIDA) LTD
SPECTRUM FILTRATION PVT. LTD
DUFLON POLYMERS
ROTO PUMPS LTD
MUNDRA PORT & SPECIAL ECONOMIC ZONE LTD
SURAJ STAINLESS LTD
EVERGREEN TECHNOLOGIES PVT. LTD.
40
PANAM ENGINEERS LTD
CMYK
CMYK
What Participants Said
There were a number of business visitors from India
and abroad at our stall. We are very happy at the
response to our participation at Chemtech + Pharma
World Expo 2007, which will help us in expanding our
business.
MR. SAMEER RANE
National Sales Manager, FETTE Compacting India
Displaying our specialized equipment at Chemtech +
Pharma World Expo 2007 on a continuous basis, has
evinced keen interest by overseas visitors and our
exports has been steadily increasing.
MR. RAVI NAIR.
Managing Director,
Acmefil Engineering Systems P Ltd
Participation at Chemtech +Pharma World Expo 2007
has been very fruitful for us, as a number of enquiries
and some orders have been received for our innovative
Products.
MR. SIDHARTH RAJ LUTHRA
Managing Director, Sukhras Machine Pvt. Ltd.
With a number of business visitors at our stall, we
have been able to expand the list of new clients,
which will be useful for our business.
MR. P. K. KHOSLA
Managing Director, Khosla Profil Pvt. Ltd.
We thank Pharma World Expo 2007 because of
which we received a large order from GHANA worth
millions.
MR. AMIT MARFATIA
Managing Director, Electrolabs
We have benefitted from our participation at
CHEMTECH + Pharma World Expo 2007. Amongst
many enquiries and prestigious orders, we sold our
Coronet Solvent Recovery Systems to M/s. Biocon
Ltd., Bangalore for Rs. 24 Lacs.
MR. VINOD JAGASIA
Director, Consite Engineering Company Ltd.
We are thankful to the organizers of Chemtech +
Pharma World Expo, for the wonderful event and
getting us direct contacts with customers. We got
an overwhelming response.
MR. RAMESH PATEL
Managing Director,
Dinshaw Filtration Systems Pvt. Ltd.
MEET OF T
IA
WORLD
Our purpose is to look for opportunities to establish a
long-term cooperation with associated organizations
to promote the development of pharmaceutical
industry both in India and China. We would like to give
our special thanks to CHEMTECH Secretariat for their
warm welcome and strong support in doing
everything.
MR. CHEN HU SHENG
Vice President,
China Association for Pharmaceutical Equipments
Truly the No.1 & Best International Event of India in
terms of both quality and event management
MR. DEAN SEGAL
Vice President of POPE Scientific Inc., USA
41
CMYK
CMYK
Cultural Function, Musical Extravaganza & Gala Dinner
CMYK
cmyk
CHEMTECH + PHARMA-BIO
WORLD EXPO 2009
WORLD MEET
2009
OF THE
PROCESS INDUSTRY
IN
INDIA
WORLD EXPO 2009
24th International Exhibition & Conference
February 10-14, 2009
Venue : Bombay Exhibition Centre, NSE Complex, Goregaon, Mumbai, India.
Scope of the Event
• Process Plant Equipment & Accessories
• Pharma & Biotechnology
• Petrochemicals & Polymers
• Environment & Safety
• Feed Stocks
• Engineering, EPC, LSTK & Other Services
Supported by :
Organised by :
CHEMTECH Secretariat
26 Maker Chambers VI, 2nd Floor, Nariman Point, Mumbai 400 021 India.
Tel: +91-22-4037 3737, 2287 4758/59, Fax: +91 22 2287 0502,
Email: [email protected], Website : www.chemtech-online.com
Regional Offices
Ahmedabad
Baroda
Bangalore
Chennai
:
:
:
:
:
Telephone
079-25831042
0265-2337189
080-25543303/04
044-28235186/89
Mobile
09898075697
09898007517
09940100665
09940100665
Email
[email protected]
[email protected]
[email protected]
[email protected]
Regional Offices
Delhi
Kolkata
Pune
:
:
:
:
Telephone
011-26293174/75
033-22317346/44
020-24494572
Mobile
09811507988
09830272734
09822209183
Email
[email protected]
[email protected]
[email protected]
cmyk
CMYK
CHEMTECH Secretariat
DIVISION OF JASUBHAI MEDIA PVT. LTD.
AN ISO 9001:2000 CERTIFIED COMPANY
26, Maker Chambers VI, 2nd Floor, Nariman Point, Mumbai 400 021, India.
Tel.: +91-22-4037 3737, 2287 4758/59 Fax: +91 22 2287 0502
Email: [email protected],
Website: www.chemtech-online.com
Delhi Office:
803, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110 019, India.
Tel: 91-11-2629 3174/75, 2648 3993/94, Fax: 91-11-2642 7404,
Email: [email protected], [email protected]
Ahmedabad
64/A, Phase-I, GIDC Industrial Estate
Vatwa, Ahmedabad 382 445.
Tel: +91 (079) 25831042,
Fax: +91 (079) 25831825
Mobile : +91(0) 9898075697
Email: [email protected]
Baroda
202, Concorde Building,
R. C. Dutt Road, Alkapuri,
Baroda - 390 007.
Tel: +91(0265) 2337189
Fax: +91(0265) 2337189
Mobile: +91 (0) 9898007517.
Email: [email protected]
Kolkata
Centre Point, 4th Floor, Room No 407,
21, Hemanta Basu Sarani, Kolkata - 700 001
Tel: +91 (033) 2231 7346 / 44
Fax: +91 (033) 2213 5549
Mobile: +91 (0) 9830272734
E-mail: [email protected]
Bangalore
96, Osborne Road
Bangalore- 560 042
Tel : +91 (080) 2554 3303/ 04,
2554 6370-73
Fax: +91 (080) 51518330
Chennai / Coimbatore
1st Floor, Jhaver Plaza,
1-A, Nungambakkam High Road,
Nungambakkam, Chennai - 600 034.
Tel: +91(044) 2823 5186-89
Fax : +91(044) 2823 0731
Mobile: +91 (0) 9940100665
Email : [email protected]
Pune
Suite 201, White House 1482,
Sadashiv Peth, Tilak Road,
Pune - 411 030
Tel : +91 (020) 2449 4572
Telefax: +91(020) 2448 2059
Mobile: +91 (0) 9822209183
E-mail: [email protected]
Q-5000-04-2007
REGIONAL OFFICES
CMYK

CHEMTECH World Expo - Chemtech Foundation

Transcription

Similar documents

A golden opportunity to A golden opportunity to

AVS24 2.4 GHZ Wireless Audio/Video Sender

HEMINEVRIN - Alcohol and Alcoholism

No trophy could ever fully express our

Chaise Lounge

Building Capacity, Creating Jobs, Discovering and Developing

Final New Corporate overview - PRINTING.

New User FFM Marketplace Testing

2013 dt 04.07.2013 on th - the official website of Bangalore Customs

WELCOME TO VARIOSYSTEMS